AG007ZDX

138-14-7 | Deferoxamine mesylate

AG007ZDX

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	138-14-7
Catalog Number	AG007ZDX(AGN-PC-0PM98X)
Chemical Name	Deferoxamine mesylate
EC Number	205-314-3
IUPAC Name	N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid
InChI	InChI=1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4)
InChI Key	IDDIJAWJANBQLJ-UHFFFAOYSA-N
MDL Number	MFCD00058605
Molecular Formula	C26H52N6O11S
Molecular Weight	656.7897
SMILES	O=C(N(O)CCCCCNC(CCC(N(CCCCCN)O)=O)=O)CCC(NCCCCCN(O)C(C)=O)=O.CS(=O)(O)=O
UNII	V9TKO7EO6K
Synonyms	Deferoxamine, Deferoxamine B, Deferoxamine Mesilate, Deferoxamine Mesylate, Deferoxamine Methanesulfonate, Deferoximine, Deferrioxamine B, Desferal, Desferioximine, Desferrioxamine, Desferrioxamine B, Desferrioxamine B Mesylate, Desferroxamine, Mesilate, Deferoxamine, Mesylate, Deferoxamine, Mesylate, Desferrioxamine B, Methanesulfonate, Deferoxamine, Deferoxamine mesylate, 138-14-7, Desferrioxamine B mesylate, Desferal, Desferrioxamine mesylate, Deferoxamine mesilate, Desferal mesylate, Deferoxamine B mesylate, Deferoxamine methanesulfonate, Desferrioxamine methanesulfonate, Deferoxamine (mesylate), Desferal methanesulfonate, Deferoxamine mesylate salt, UNII-V9TKO7EO6K, DFX mesylate, Desferioxamine mesylate, EINECS 205-314-3, Ba 33122, V9TKO7EO6K, Desferrioxamine mesylate salt, Desferrioxamine B methanesulfonate, DESFERRIOXAMINE MESILATE, MLS000028713, Deferoxamine methanesulfonate salt, MFCD00058605, NCGC00017021-01, CAS-138-14-7, Desferal (TN), Deferoxamine-D8 mesylate, DSSTox_CID_17649, DSSTox_RID_79351, DSSTox_GSID_37649, N-(5-(3-((5-Aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)propionohydroxamic acid monomethanesulfonate (salt), CHEBI:31460, Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate, Propionohydroxamic acid, N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)-, monomethanesulfonate (salt), NSC644468, SR-01000695424, SMR000058548, 138D147, Deferoxamine mesylate [USAN], CCRIS 8311, C25H48N6O8.CH4O3S, Deferoxamine mesylate [USAN:USP], Prestwick_988, deferoxamine-mesylate, Deforoxamine B mesylate, AC1Q5IOG, AC1L1XZ1, CHEMBL1234, Deferoxamine mesylate, 95%, Deferoxamine mesylate (USP), KSC959A0B, SCHEMBL119982, SPECTRUM1500224, Deferoxamine mesilate (JP17), Deferrioxamine B methanesulfonate, DTXSID6037649, CTK8F9000, HMS500E04, C26H52N6O11S, IDDIJAWJANBQLJ-UHFFFAOYSA-N, HMS1570A12, HMS1920C16, HMS2091K08, HMS2097A12, HMS2234H23, HMS3714A12, Pharmakon1600-01500224, HY-B0988, Tox21_110741, CCG-39770, NSC756718, AKOS026750165, Tox21_110741_1, CS-4479, NSC 644468, NSC-644468, NSC-756718, NCGC00017021-02, NCGC00017021-03, NCGC00094640-01, NCGC00094640-02, NCGC00178802-06, AN-43810, BC667333, AB0035971, LS-124966, FT-0603121, ST24046423, Y0490, D01186, A807339, SR-01000695424-2, SR-01000695424-3, SR-01000695424-4, Deferoxamine mesylate salt, powder, >=92.5% (TLC), I14-98954, Deferoxamine mesylate salt, European Pharmacopoeia (EP) Reference Standard, Deferoxamine mesylate, United States Pharmacopeia (USP) Reference Standard, Deferoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard, N'-(5-azanylpentyl)-N-[5-[[4-[5-[ethanoyl(oxidanyl)amino]pentylamino]-4-oxidanylidene-butanoyl]-oxidanyl-amino]pentyl]-N'-oxidanyl-butanediamide; methanesulfonic acid, N'-{5-[acetyl(hydroxy)amino]pentyl}-N-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-N-hydroxysuccinamide methanesulfonate (salt), n'-{5-[acetyl(hydroxy)amino]pentyl}-n-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-n-hydroxysuccinamide methanesulfonate(1:1), N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-1,4-dioxobutyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide; methanesulfonic acid, N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide; methanesulfonic acid, N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid, N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid Methanesulfonate, N1-(5-aminopentyl)-N1-hydroxy-N4-(5-(N-hydroxy-4-(5-(N-hydroxyacetamido)pentylamino)-4-oxobutanamido)pentyl)succinamide methanesulfonate, N1-(5-aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide Methanesulfonate, N4-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxybutanediamide methanesulfonate, N4-[5-[[4-5-(Acetylhydroxyamino)pentyl]-1,4-dioxobutyl]hydroxyaminopentyl-N1-(5-aminopentyl)-N1-hydroxybutanediamide methanesulfonate, deferoxamine, DFOM, Desferrioxamine B, D0FJ8A, Ba-33112, CID62881, Ba 33112, Deferoxamine mesylate salt, 97% - 1G 1g, C25-H48-N6-O8.C-H4-O3-S, Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate (salt), Butanediamide, N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate (salt), Butanodiamida, N4-[5-[[4-[[5-(acetilhidroxiamino)pentil]amino]-1,4-dioxobutil]hidroxiamino] pentil]-N1-(5-aminopentil)-N1-hidroxi-, metanosulfonato (1:1),

Complexity	832
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	656.341g/mol
Formal Charge	0
Heavy Atom Count	44
Hydrogen Bond Acceptor Count	12
Hydrogen Bond Donor Count	7
Isotope Atom Count	0
Molecular Weight	656.793g/mol
Monoisotopic Mass	656.341g/mol
Rotatable Bond Count	23
Topological Polar Surface Area	269A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number